NHS Framework Agreement for Branded Medicines - National
A Contract Award Notice
by NHS ENGLAND
- Source
- Contracts Finder
- Type
- Framework (Products)
- Duration
- 1.5 year
- Value
- £149M
- Sector
- HEALTH
- Published
- 19 Oct 2021
- Delivery
- 01 Nov 2021 to 30 Apr 2023
- Deadline
- 02 Jul 2021 13:00
Concepts
Location
1 buyer
- NHS England Runcorn
37 suppliers
- Napp Pharmaceuticals Cambridge
- Accord None
- Martindale Pharma None
- Takeda London
- Pfizer None
- Kent Pharma Heathrow
- Aspen Pharmacare None
- Glenmark Pharmaceuticals Europe Watford
- Mylan Barnet
- Tillomed Laboratories Luton
- Medac Pharma Stirling
- Ipsen Slough
- Bayer Reading
- Wockhardt Wrexham
- Morningside Pharmaeuticals Northampton
- Zentiva Pharma London
- Sandoz Camberley
- Ul Global Pharma Watford
- Teva Castleford
- Qdem Pharmaceuticals Cambridge
- Day Lewis Medical None
- Aventis Pharma None
- Tetris Pharma Northampton
- Novartis Pharmaceuticals London
- Ferring Pharmaceuticals West Drayton
- Ridge Pharma Reading
- Merck Serono Feltham
- Dexcel Pharma Daventry
- Flynn Pharma County Dublin
- Gedeon Richter Maida Vale
- Chiesi Manchester
- Aspire Pharma None
- Pharmasure Watford
- Theramex HQ London
- Astellas Pharma None
- Orifarm None
- Nordic Pharma Theale
Description
NHS Framework Agreement for Branded Medicines - National FIND A TENDER (FTS) Reference number: FTS-002612 Offer reference number: CM/PHR/20/5610 CM/PHR/20/5610/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Period of framework: 1 November 2021 to 31 October 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5610/02 - NHS Framework Agreement for Branded Medicines - National Tender Period of framework: 1 November 2021 to 30 April 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 18 months
Award Detail
1 | Napp Pharmaceuticals (Cambridge)
|
2 | Accord (None)
|
3 | Martindale Pharma (None)
|
4 | Takeda (London)
|
5 | Pfizer (None)
|
6 | Kent Pharma (Heathrow)
|
7 | Aspen Pharmacare (None)
|
8 | Glenmark Pharmaceuticals Europe (Watford)
|
9 | Mylan (Barnet)
|
10 | Tillomed Laboratories (Luton)
|
11 | Medac Pharma (Stirling)
|
12 | Ipsen (Slough)
|
13 | Bayer (Reading)
|
14 | Wockhardt (Wrexham)
|
15 | Morningside Pharmaeuticals (Northampton)
|
16 | Zentiva Pharma (London)
|
17 | Sandoz (Camberley)
|
18 | Ul Global Pharma (Watford)
|
19 | Teva (Castleford)
|
20 | Qdem Pharmaceuticals (Cambridge)
|
21 | Day Lewis Medical (None)
|
22 | Aventis Pharma (None)
|
23 | Tetris Pharma (Northampton)
|
24 | Novartis Pharmaceuticals (London)
|
25 | Ferring Pharmaceuticals (West Drayton)
|
26 | Ridge Pharma (Reading)
|
27 | Merck Serono (Feltham)
|
28 | Dexcel Pharma (Daventry)
|
29 | Flynn Pharma (None)
|
30 | Gedeon Richter (Maida Vale)
|
31 | Chiesi (Manchester)
|
32 | Aspire Pharma (None)
|
33 | Pharmasure (Watford)
|
34 | Theramex HQ (London)
|
35 | Astellas Pharma (None)
|
36 | Orifarm (None)
|
37 | Nordic Pharma (Theale)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract is suitable for SMEs.
Other Information
Parties Appointed to Framework#2 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NaKS/Hjf1bLRivDp... CM_PHR_20_5610_02 National Proprietary Medicines Framework 1 November 2021 - Transparency Award Schedule#2 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NaKX/W7.se6PY8lL... 03. Framework Agreement and Terms and Conditions -CM_PHR_20_5610 NHS Framework Agreement for Branded Medicines#2 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NaKh/VAvWStdi4WE... CM_PHR_20_5610_01 National Proprietary Medicines Category Framework 1 November 2021 Transparency Award Schedule#2 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NaK4/U9Z_ZCWIr5V...
Reference
- CF-0387600D0O000000rwimUAA1
- CF ad668311-0540-4e17-b81f-0920d2db574d